
Novan, Inc. – NASDAQ:NOVN
Novan stock price today
Novan stock price monthly change
Novan stock price quarterly change
Novan stock price yearly change
Novan key metrics
Market Cap | 2.63M |
Enterprise value | 20.45M |
P/E | -1.03 |
EV/Sales | 0.64 |
EV/EBITDA | -0.37 |
Price/Sales | 0.90 |
Price/Book | 6.26 |
PEG ratio | -0.01 |
EPS | 0.12 |
Revenue | 24.71M |
EBITDA | -32.08M |
Income | 999K |
Revenue Q/Q | 58.35% |
Revenue Y/Y | 522.98% |
Profit margin | -89.05% |
Oper. margin | -198.69% |
Gross margin | 67.9% |
EBIT margin | -198.69% |
EBITDA margin | -129.83% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNovan stock price history
Novan stock forecast
Novan financial statements
Jun 2022 | 6.15M | -9.01M | -146.53% |
---|---|---|---|
Sep 2022 | 5.09M | -2.44M | -47.91% |
Dec 2022 | 10.46M | 26.57M | 253.88% |
Mar 2023 | 2.99M | -14.11M | -471.26% |
Jun 2022 | 114392000 | 102.14M | 89.29% |
---|---|---|---|
Sep 2022 | 83270000 | 76.51M | 91.88% |
Dec 2022 | 90330000 | 85.72M | 94.9% |
Mar 2023 | 79793000 | 82.62M | 103.54% |
Jun 2022 | -11.11M | -1.87M | 14.79M |
---|---|---|---|
Sep 2022 | -9.43M | -3.00M | -9.96M |
Dec 2022 | -11.10M | -1.06M | 10.63M |
Mar 2023 | -4.25M | -23K | 4.09M |
Novan alternative data
Aug 2023 | 90 |
---|---|
Sep 2023 | 90 |
Oct 2023 | 90 |
Nov 2023 | 90 |
Dec 2023 | 90 |
Jan 2024 | 90 |
Feb 2024 | 90 |
Mar 2024 | 90 |
Apr 2024 | 90 |
May 2024 | 90 |
Jun 2024 | 90 |
Jul 2024 | 90 |
Novan other data
Period | Buy | Sel |
---|---|---|
Mar 2022 | 24000 | 0 |
Apr 2022 | 1000 | 0 |
Patent |
---|
Application Filling date: 18 Feb 2022 Issue date: 2 Jun 2022 |
Application Filling date: 20 Aug 2021 Issue date: 21 Apr 2022 |
Grant Filling date: 1 Mar 2019 Issue date: 29 Mar 2022 |
Grant Filling date: 5 Feb 2019 Issue date: 29 Mar 2022 |
Application Filling date: 3 Sep 2021 Issue date: 23 Dec 2021 |
Application Filling date: 25 May 2021 Issue date: 11 Nov 2021 |
Grant Filling date: 13 Apr 2017 Issue date: 9 Nov 2021 |
Application Filling date: 28 Jun 2021 Issue date: 21 Oct 2021 |
Grant Utility: Tunable nitric oxide-releasing macromolecules having multiple nitric oxide donor structures Filling date: 29 Aug 2019 Issue date: 21 Sep 2021 |
Grant Filling date: 28 Feb 2013 Issue date: 3 Aug 2021 |
Quarter | Transcript |
---|---|
Q1 2023 15 May 2023 | Q1 2023 Earnings Call Transcript |
Q4 2022 30 Mar 2023 | Q4 2022 Earnings Call Transcript |
Q3 2022 15 Nov 2022 | Q3 2022 Earnings Call Transcript |
Q2 2022 11 Aug 2022 | Q2 2022 Earnings Call Transcript |
Insider | Compensation |
---|---|
Ms. Paula Brown Stafford M.P.H. (1965) Pres, Chief Executive Officer & Chairwoman | $897,860 |
Mr. John M. Gay CPA (1976) Chief Financial Officer & Corporation Sec. | $408,030 |
-
What's the price of Novan stock today?
One share of Novan stock can currently be purchased for approximately $0.09.
-
When is Novan's next earnings date?
Unfortunately, Novan's (NOVN) next earnings date is currently unknown.
-
Does Novan pay dividends?
No, Novan does not pay dividends.
-
How much money does Novan make?
Novan has a market capitalization of 2.63M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 736.61% to 23.61M US dollars.
-
What is Novan's stock symbol?
Novan, Inc. is traded on the NASDAQ under the ticker symbol "NOVN".
-
What is Novan's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Novan?
Shares of Novan can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Novan's key executives?
Novan's management team includes the following people:
- Ms. Paula Brown Stafford M.P.H. Pres, Chief Executive Officer & Chairwoman(age: 60, pay: $897,860)
- Mr. John M. Gay CPA Chief Financial Officer & Corporation Sec.(age: 49, pay: $408,030)
-
How many employees does Novan have?
As Jul 2024, Novan employs 90 workers.
-
When Novan went public?
Novan, Inc. is publicly traded company for more then 8 years since IPO on 21 Sep 2016.
-
What is Novan's official website?
The official website for Novan is novan.com.
-
Where are Novan's headquarters?
Novan is headquartered at 4020 Stirrup Creek Drive, Durham, CA.
-
How can i contact Novan?
Novan's mailing address is 4020 Stirrup Creek Drive, Durham, CA and company can be reached via phone at +91 94858080.
Novan company profile:

Novan, Inc.
novan.comNASDAQ
90
Biotechnology
Healthcare
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, an anti-viral product candidate for the treatment of external genital warts; WH602, a nitric oxide-containing intravaginal gel to treat high-risk human papilloma virus (HPV); WH504, a non-gel formulation product candidate to treat high-risk HPV; and SB019 for the treatment of SARS-CoV-2. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. Novan, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
Durham, CA 27703
CIK: 0001467154
ISIN: US66988N2053
CUSIP: 66988N205